AI Rad Companion (Engine)
Siemens Medical Solutions USA, Inc. • Radiology • 02/01/2019
Device Purpose
The AI-Rad Companion (Engine) is a software platform designed to assist technicians and trained physicians by providing visualization, storage, and transfer capabilities for medical images, supporting qualitative and quantitative analysis of clinical data for diagnostic purposes. It operates through a DICOM-compatible interface for multi-modality data, integrates external post-processing extensions including those using artificial intelligence, features user interfaces for confirmation and configuration, and is deployable on Siemens' cloud infrastructure with updates enhancing access to extensions and workflow visualization.
Summary
The AI-Rad Companion (Engine) is a software platform developed by Siemens Medical Solutions USA, Inc., designed for basic visualization and to enable external post-processing extensions for medical images used in diagnostic procedures. Its primary purpose is to support technicians and trained physicians in the qualitative and quantitative measurement and analysis of clinical data. The platform facilitates the storage of data and its transfer to other systems, such as PACS, and provides an interface for integrating various processing extensions. Key functionalities include a multi-modality and multi-vendor DICOM data interface, data validity checks using DICOM tags, an interface for post-processing extensions, and user interfaces for visualizing processed images and configuring the device and its extensions. Updates to the device include a modified indications for use statement and support for software version VA10A, which enables deployment on Siemens cloud infrastructure, an improved method for accessing and configuring optional post-processing extensions, and a modified workflow for visualizing and confirming their output. Performance of the AI-Rad Companion (Engine) was established through non-clinical testing, including software validations and bench testing encompassing unit, subsystem, and system integration tests. These tests confirmed the device's functionality and compliance with several industry standards, such as DICOM (NEMA PS 3.1-3.20), IEC 62304 for medical device software life cycle processes, ISO 14971 for risk management, and IEC 62366-1 for usability engineering. A risk analysis was completed, and mitigation measures were implemented. Cybersecurity considerations are addressed through processes to prevent unauthorized access and misuse of information, aligning with IEC 80001-1. Human factor usability validation was also conducted, ensuring the system is suitable for trained users in clinical environments. The testing confirmed that all software specifications met acceptance criteria, supporting its intended use for enhancing clinical data analysis.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. Regarding the 'improved method to access and configure optional post-processing extensions,' what specific improvements were made to the user interface or workflow, and how do these impact efficiency or ease of use?; The document mentions 'extensions that can perform automated post-processing using artificial intelligence algorithms.' What types of AI algorithms are supported by the platform, and what is the validation process specifically for these AI-driven extensions?; How does the deployment on Siemens cloud infrastructure affect data security, latency, and accessibility for different clinical settings, particularly those with potentially limited or variable internet bandwidth?; Could you elaborate on the 'Human Factor Usability Validation' process, including the specific tasks evaluated, the user profiles involved (e.g., technicians, physicians), and the key findings or improvements resulting from these tests?; The device is designed to support 'qualitative and quantitative measurement and analysis of clinical data.' What specific quantitative tools are inherently provided by the AI-Rad Companion (Engine) platform itself, versus those expected to be delivered via extensions, and what is their validated accuracy or performance?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of SBOM, ML-BOM, SaaSBOM, OBOM detected in AI-generated device summary.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly